Zhi Yang

Shanghai Bioveda Investment Management Consulting Co. Ltd. (BioVeda China) is an independent Chinese venture capital firm which was established by Dr. Zhi Yang when BioVeda Capital spun off their China Fund. Headquartered in Shanghai, BioVeda China is the first international life science venture capital firm in China and manages the BioVeda China Fund, backed by blue chip international institutional and corporate investors. The firm's Scientific Advisory Board, comprised of international experts from China and the West, supports BioVeda China by acting as a business and scientific bridge between companies in China and the West, linking finance and technology between the two markets.

Nexchem Pharmaceutical Co., Ltd. produces active pharmaceutical ingredients for global markets. Its products encompass azithromycin dihydrate, clarithromycin, roxithromycin, meropenem, fenofibrate, benserazide hydrochloride, and levosulpiride. The company was founded in December 2002 and is headquartered in Jinhua, China.

Part of Shanghai Bioveda Investment Management Consulting Co. Ltd., BVCF Investment Consulting (Shanghai) Ltd. is a healthcare investment company based in Shanghai, China. BVCF actively assists business owners and entrepreneurs to build their companies into world-class businesses. The Chinese company has raised five funds and invests in growth-stage healthcare companies from around the world, with a particular focus on innovative solutions that address unmet health needs. The company was founded by Zhi Yang and Ya Chao Zhao has been the CEO of the company since 2007.

MicuRx Pharmaceuticals, Inc. is a holding company, which engages in the discovery, development, and commercialization of safe and effective antimicrobial therapeutics for multidrug-resistant superbag infections. The company was founded by Zheng Yu Yuan and Mikhail Fedorovich Gordeev in March 2007 and is headquartered in Pudong, China.

Jaguar Animal Health, Inc. engages in the development and commercialization of gastrointestinal products for companion and production animals. Its product, Canalevia, is the company's prescription drug product candidate for the treatment of various forms diarrhea in dogs. It also developed its non-prescription product, Neonorm Calf, which helps dairies and beef farms proactively retain fluid in calves. The company was founded by Lisa A. Conte on June 6, 2013 and is headquartered in San Francisco, CA.

NOD Pharmaceuticals, Inc. manufactures and distributes pharmaceutical products. It focuses on developing oral formulations for insulin, exenatide, interferon, human growth hormone, and more. The company was founded in 2005 and is headquartered in San Diego, CA.